| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2005 ( Subtotal = $0 ) |
| | 2005 | 2004 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | H39OT00099 | MODEL INTERVENTIONS TO INCREASE ORGAN AND TISSUE DONATION | 001 | 3 | HRSA | 9/21/2005 | $0 |
|
| Issue Date FY: 2004 ( Subtotal = $282,030 ) |
| | 2004 | 2004 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | H39OT00099 | MODEL INTERVENTIONS TO INCREASE ORGAN AND TISSUE DONATION | 000 | 3 | HRSA | 9/27/2004 | $282,030 |
| | 2004 | 2003 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | H39OT00099 | MODEL INTERVENTIONS TO INCREASE ORGAN AND TISSUE DONATION | 001 | 2 | HRSA | 8/11/2004 | $0 |
|
| Issue Date FY: 2003 ( Subtotal = $1,518,840 ) |
| | 2003 | 2003 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R21HL072298 | USE OF PROTEOGLYCAN-GENES TO ENGINEER VASCULAR TISSUE | 000 | 2 | NIH | 8/4/2003 | $273,750 |
| | 2003 | 2003 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01EY014150 | LENS BASEMENT MEMBRANE IN SPARC-NULL CATARACTOGENESIS | 000 | 2 | NIH | 8/11/2003 | $273,750 |
| | 2003 | 2003 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R21EB002386 | ATRIAL WALL: A 3-D SCAFFOLD WITH FORMED MICROVASCULATURE | 000 | 1 | NIH | 9/16/2003 | $273,750 |
| | 2003 | 2003 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01HL067172 | SHEAR STRESS MODULATION OF WNT SIGNALING | 000 | 3 | NIH | | $180,500 |
| | 2003 | 2003 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R21DK066487 | CONTROL OF ADIPOCYTE HYPERTROPHY BY EXTRACELLULAR MATRIX | 000 | 1 | NIH | 9/8/2003 | $232,500 |
| | 2003 | 2003 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | H39OT00099 | MODEL INTERVENTIONS TO INCREASE ORGAN AND TISSUE DONATION | 000 | 2 | HRSA | 9/17/2003 | $284,590 |
|
| Issue Date FY: 2002 ( Subtotal = $1,842,897 ) |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | K01CA089689 | REGULATION OF FGF 2 MEDIATED ANGIOGENESIS BY SPARC | 000 | 2 | NIH | 2/19/2002 | $144,126 |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | H39OT00099 | MODEL INTERVENTIONS TO INCREASE ORGAN AND TISSUE DONATION | 000 | 1 | HRSA | 9/26/2002 | $282,030 |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01AI037747 | TOLERANCE IN PRIMATES--THYMIC IMPLANTATION OF STEM CELL | 000 | 6 | NIH | 1/28/2002 | $1 |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01HL067172 | SHEAR STRESS MODULATION OF WNT SIGNALING | 000 | 2 | NIH | 4/1/2002 | $180,500 |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | F32HL010352 | SPARC AS A REGULATOR OF VEGF ACTIVITY | 000 | 3 | NIH | 5/13/2002 | $9,532 |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01EY014150 | LENS BASEMENT MEMBRANE IN SPARC-NULL CATARACTOGENESIS | 000 | 1 | NIH | 9/16/2002 | $273,750 |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R21HL072298 | USE OF PROTEOGLYCAN-GENES TO ENGINEER VASCULAR TISSUE | 000 | 1 | NIH | 9/19/2002 | $273,750 |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01HL071148 | PLAQUE PROGRESSION, APOPTOSIS AND INFLAMMATION | 000 | 1 | NIH | 8/30/2002 | $273,836 |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | K01AR002220 | SPARC MODULATES EXTRACELLULAR MATRIX DYNAMICS IN SKIN | 000 | 2 | NIH | 6/28/2002 | $105,011 |
| | 2002 | 2002 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01HL059475 | REGULATION OF VASCULAR GROWTH BY COLLAGEN I AND SPARC | 000 | 5 | NIH | 11/29/2001 | $300,361 |
|
| Issue Date FY: 2001 ( Subtotal = $1,088,825 ) |
| | 2001 | 2001 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | F32EY006987 | SPARC AND CATARACTOGENESIS IN MICE | 000 | 3 | NIH | 6/27/2001 | $49,412 |
| | 2001 | 2001 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | K01AR002220 | SPARC MODULATES EXTRACELLULAR MATRIX DYNAMICS IN SKIN | 000 | 1 | NIH | 7/10/2001 | $101,952 |
| | 2001 | 2001 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R18AI040674 | COMMUNITY-BASED PLAN TO INCREASE MINORITY ORGAN DONATION | 000 | 6 | NIH | 8/31/2001 | $306,014 |
| | 2001 | 2001 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01HL067172 | SHEAR STRESS MODULATION OF WNT SIGNALING | 000 | 1 | NIH | 9/11/2001 | $180,500 |
| | 2001 | 2001 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | F32HL010352 | SPARC AS A REGULATOR OF VEGF ACTIVITY | 000 | 2 | NIH | 5/31/2001 | $40,196 |
| | 2001 | 2001 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01HL059475 | REGULATION OF VASCULAR GROWTH BY COLLAGEN I AND SPARC | 000 | 4 | NIH | 12/1/2000 | $286,119 |
| | 2001 | 2001 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | K01CA089689 | REGULATION OF FGF 2 MEDIATED ANGIOGENESIS BY SPARC | 000 | 1 | NIH | 2/14/2001 | $124,632 |
|
| Issue Date FY: 2000 ( Subtotal = $661,936 ) |
| | 2000 | 2000 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | F32EY006987 | SPARC AND CATARACTOGENESIS IN MICE | 000 | 2 | NIH | 6/26/2000 | $46,300 |
| | 2000 | 2000 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | F32HL010352 | SPARC AS A REGULATOR OF VEGF ACTIVITY | 000 | 1 | NIH | 4/1/2000 | $32,416 |
| | 2000 | 2000 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R18AI040674 | COMMUNITY-BASED PLAN TO INCREASE MINORITY ORGAN DONATION | 000 | 4 | NIH | 10/2/2000 | $0 |
| | 2000 | 2000 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R18AI040674 | COMMUNITY-BASED PLAN TO INCREASE MINORITY ORGAN DONATION | 000 | 5 | NIH | 9/27/2000 | $297,101 |
| | 2000 | 2000 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01HL059475 | REGULATION OF VASCULAR GROWTH BY COLLAGEN I AND SPARC | 000 | 3 | NIH | 11/29/1999 | $286,119 |
|
| Issue Date FY: 1999 ( Subtotal = $283,098 ) |
| | 1999 | 1999 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | F32EY006987 | SPARC AND CATARACTOGENESIS IN MICE | 000 | 1 | NIH | 6/30/1999 | $45,268 |
| | 1999 | 1999 | THE HOPE HEART INSTITUTE | 556 18TH AVENUE | SEATTLE | WA | 98122 | KING | USA | R01HL059475 | REGULATION OF VASCULAR GROWTH BY COLLAGEN I AND SPARC | 000 | 2 | NIH | 7/15/1999 | $237,830 |
|
|
